These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21876471)

  • 21. MicroRNAs and cancer--new paradigms in molecular oncology.
    Negrini M; Nicoloso MS; Calin GA
    Curr Opin Cell Biol; 2009 Jun; 21(3):470-9. PubMed ID: 19411171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-21 as a key regulator of oncogenic processes.
    Selcuklu SD; Donoghue MT; Spillane C
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):918-25. PubMed ID: 19614619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs and their target gene networks in renal cell carcinoma.
    Redova M; Svoboda M; Slaby O
    Biochem Biophys Res Commun; 2011 Feb; 405(2):153-6. PubMed ID: 21232526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNAs in human cancer: from research to therapy.
    Negrini M; Ferracin M; Sabbioni S; Croce CM
    J Cell Sci; 2007 Jun; 120(Pt 11):1833-40. PubMed ID: 17515481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA expression in the eyes and their significance in relation to functions.
    Xu S
    Prog Retin Eye Res; 2009 Mar; 28(2):87-116. PubMed ID: 19071227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer.
    Wang J; Wang Q; Liu H; Hu B; Zhou W; Cheng Y
    Cancer Lett; 2010 Nov; 297(2):137-43. PubMed ID: 20797817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic role of microRNAs in brain tumors.
    Pang JC; Kwok WK; Chen Z; Ng HK
    Acta Neuropathol; 2009 Jun; 117(6):599-611. PubMed ID: 19343354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNAs, ultraconserved genes and colorectal cancers.
    Rossi S; Kopetz S; Davuluri R; Hamilton SR; Calin GA
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1291-7. PubMed ID: 19497386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond genomics: interpreting the 93% of the human genome that does not encode proteins.
    Fabbri M; Calin GA
    Curr Opin Drug Discov Devel; 2010 May; 13(3):350-8. PubMed ID: 20443168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
    Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
    Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oncogenic and tumour suppressor microRNAs].
    Finoux AL; Chartrand P
    Med Sci (Paris); 2008 Dec; 24(12):1049-54. PubMed ID: 19116113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
    Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
    Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
    Gaur A; Jewell DA; Liang Y; Ridzon D; Moore JH; Chen C; Ambros VR; Israel MA
    Cancer Res; 2007 Mar; 67(6):2456-68. PubMed ID: 17363563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
    Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
    Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.
    Cui SY; Wang R; Chen LB
    J Cell Mol Med; 2014 Oct; 18(10):1913-26. PubMed ID: 25124875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bottleneck limitations for microRNA-based therapeutics from bench to the bedside.
    Chen Y; Zhao H; Tan Z; Zhang C; Fu X
    Pharmazie; 2015 Mar; 70(3):147-54. PubMed ID: 25980175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microRNAs: Association with disease and potential use as biomarkers.
    Reid G; Kirschner MB; van Zandwijk N
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):193-208. PubMed ID: 21145252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs as novel biological targets for detection and regulation.
    Li J; Tan S; Kooger R; Zhang C; Zhang Y
    Chem Soc Rev; 2014 Jan; 43(2):506-17. PubMed ID: 24161958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.